Medicare Enrolled
Dr. Laila Hassan, M.D. P.A.
Preferred Provider Organization · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hassan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hassan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hassan
Dr. Laila Hassan is a preferred provider organization specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hassan performed 161,562 Medicare services across 2,238 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hassan received a total of $17,965 from 57 pharmaceutical and/or device companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in preferred provider organization. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hassan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 50% volume in TX
$17,965 industry payments
Medicare Practice Summary
Medicare Utilization ↗161,562
Medicare services
Top 50% in TX for preferred provider organization
2,238
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,503 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
61,600 | $4 | $24 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
48,690 | $11 | $80 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
17,375 | $33 | $100 |
| Romosozumab injection (Evenity) for osteoporosis | 13,860 | $7 | $20 |
| Denosumab injection (Prolia/Xgeva) | 10,560 | $18 | $67 |
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
3,104 | $13 | $31 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
2,400 | $13 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
940 | $96 | $220 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
597 | $107 | $400 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
433 | $1 | $10 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
305 | $60 | $109 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
297 | $11 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $68 | $180 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
216 | $39 | $249 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
148 | $53 | $200 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
141 | $33 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
141 | $31 | $40 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
125 | $78 | $200 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
87 | $281 | $600 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
87 | $31 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $118 | $270 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
44 | $47 | $150 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
38 | $43 | $150 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
35 | $9 | $24 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.3% high complexity
57.5% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,965
Total received (2018-2024)
Avg $2,566/year across 7 years
Top 50% in TX for preferred provider organization
57
Companies
516
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,819 (60.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,906 (32.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,240 (6.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,945
2023
$1,625
2022
$916
2021
$1,476
2020
$2,201
2019
$2,430
2018
$7,372
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$6,038
Horizon Therapeutics plc
$1,825
Amgen Inc.
$1,489
Amarin Pharma Inc.
$1,024
ABBVIE INC.
$990
AbbVie, Inc.
$560
Novartis Pharmaceuticals Corporation
$546
AstraZeneca Pharmaceuticals LP
$499
E.R. Squibb & Sons, L.L.C.
$482
UCB, Inc.
$368
Lilly USA, LLC
$332
AbbVie Inc.
$330
Janssen Biotech, Inc.
$325
GlaxoSmithKline, LLC.
$302
Novo Nordisk Inc
$230
Boehringer Ingelheim Pharmaceuticals, Inc.
$194
Radius Health, Inc.
$184
Horizon Pharma plc
$178
PFIZER INC.
$160
IBSA Pharma Inc.
$144
Genentech USA, Inc.
$133
Aurinia Pharma U.S., Inc.
$123
Mallinckrodt Hospital Products Inc.
$117
Xeris Pharmaceuticals, Inc.
$102
Merck Sharp & Dohme Corporation
$92
Dexcom, Inc.
$91
SANOFI-AVENTIS U.S. LLC
$91
Mallinckrodt Enterprises LLC
$90
Bayer Healthcare Pharmaceuticals Inc.
$90
Antares Pharma, Inc.
$83
Esperion Therapeutics, Inc.
$77
Mallinckrodt LLC
$76
Intuity Medical Inc
$48
Abbott Laboratories
$48
Corcept Therapeutics
$46
BETA BIONICS, INC.
$46
Mannkind Corporation
$37
LifeScan, Inc.
$33
Amneal Pharmaceuticals LLC
$31
Shield Therapeutics Inc
$22
CeQur Corporation
$22
Alexion Pharmaceuticals, Inc.
$21
Celgene Corporation
$19
Acella Pharmaceuticals, LLC
$19
Flexion Therapeutics, Inc.
$18
Valeritas, Inc.
$17
MEDAC PHARMA, INC.
$16
FIDIA PHARMA USA INC.
$16
Zyla Life Sciences
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Janssen Pharmaceuticals, Inc
$16
Supernus Pharmaceuticals, Inc.
$16
Medtronic, Inc.
$16
ASCEND THERAPEUTICS US, LLC
$16
MannKind Corporation
$16
Kowa Pharmaceuticals America, Inc.
$15
Endo Pharmaceuticals Inc.
$13
Top 3 companies account for 52.1% of total payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AFREZZA · AVSOLA · Actemra · BENLYSTA · BINOSTO · Bimzelx · COSENTYX · CYCLOSET · CeQur Simplicity · Cimzia · DEXCOM G6 CGM SYSTEM · Dexcom G6 Transmitter · EVENITY · Enbrel · FARXIGA · FORTEO · FREESTYLE LIBRE 3 · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · HUMIRA · Humira · Hymovis · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · KEVZARA · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LICART · LUPKYNIS · Livalo · MOUNJARO · NASCOBAL · NEXLETOL · NO PRODUCT DISCUSSED · NOCDURNA · NP Thyroid 60 · ORENCIA · OTREXUP · OneTouch · Ozempic · PENNSAID · PRALUENT · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Prolia · RAYOS · REMICADE · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIQUA · STRENSIQ · SYNTHROID · Saxenda · TALTZ · TAVNEOS · TLANDO · TREMFYA · TZIELD · Tavneos · Tirosint · Tymlos · UNITHROID · V-GO · VIMOVO · Vascepa · Wegovy · XELJANZ · XYOSTED · ZORVOLEX · Zilretta · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $11 per 100 Medicare services performed
Geographic Context
Preferred provider organizations within 10 mi
5
Per 100K population
0.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hassan is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hassan experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Hassan performed 61,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hassan receive payments from pharmaceutical companies?
Yes. Dr. Hassan received a total of $17,965 from 57 companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hassan's costs compare to other preferred provider organizations in Houston?
Dr. Hassan's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hassan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Preferred Provider Organizations in Houston
Browse preferred provider organizations in Houston ranked by procedure volume and transparency data.
Highest volume
Top Preferred Provider Organizations in TX
Preferred provider organizations ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Preferred Provider Organizations in TX
Which TX preferred provider organizations receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology